NFL officials offered a firm defense of the Philadelphia Eagles' handling of quarterback Jalen Hurts and his blood clot issue during the league's owners meetings on Tuesday in New York, with chief medical officer Allen Sills addressing reporters at a media availability.
Sills characterized the Eagles' approach as "appropriately guarded," according to ESPN, signaling that the league's medical leadership views the team's management of the situation as sound. The remarks came as team owners gathered for their regularly scheduled meetings, where league business and player health matters are routinely discussed.
The public backing from the league's top medical official carries significance for the Eagles organization and their fan base, which has closely monitored Hurts' health status. By affirming the team's process, Sills' comments may quiet external questions about how the franchise has communicated and managed the medical situation surrounding its starting quarterback.
Blood clots represent a serious medical concern for professional athletes, and the league has established protocols for evaluating and monitoring players facing such conditions. The chief medical officer's willingness to address the matter publicly suggests the league is comfortable with the safeguards in place.
For Philadelphia-area readers, the development offers reassurance that the league's medical oversight apparatus has reviewed the Eagles' handling of Hurts' situation. The team has not indicated any change to its approach following Sills' remarks.
